rs2281575
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001174089.2(SLC4A11):c.2193-18C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.44 in 1,611,638 control chromosomes in the GnomAD database, including 159,860 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.41 ( 13246 hom., cov: 32)
Exomes 𝑓: 0.44 ( 146614 hom. )
Consequence
SLC4A11
NM_001174089.2 intron
NM_001174089.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.726
Publications
15 publications found
Genes affected
SLC4A11 (HGNC:16438): (solute carrier family 4 member 11) This gene encodes a voltage-regulated, electrogenic sodium-coupled borate cotransporter that is essential for borate homeostasis, cell growth and cell proliferation. Mutations in this gene have been associated with a number of endothelial corneal dystrophies including recessive corneal endothelial dystrophy 2, corneal dystrophy and perceptive deafness, and Fuchs endothelial corneal dystrophy. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Mar 2010]
SLC4A11 Gene-Disease associations (from GenCC):
- corneal dystrophy, Fuchs endothelial, 4Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
- congenital hereditary endothelial dystrophy of corneaInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- corneal dystrophy-perceptive deafness syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia
- Fuchs' endothelial dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 20-3228725-G-A is Benign according to our data. Variant chr20-3228725-G-A is described in ClinVar as Benign. ClinVar VariationId is 261998.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.68 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC4A11 | NM_001174089.2 | c.2193-18C>T | intron_variant | Intron 17 of 19 | ENST00000642402.1 | NP_001167560.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC4A11 | ENST00000642402.1 | c.2193-18C>T | intron_variant | Intron 17 of 19 | NM_001174089.2 | ENSP00000493503.1 |
Frequencies
GnomAD3 genomes AF: 0.409 AC: 62135AN: 151924Hom.: 13239 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
62135
AN:
151924
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.443 AC: 109002AN: 245870 AF XY: 0.451 show subpopulations
GnomAD2 exomes
AF:
AC:
109002
AN:
245870
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.444 AC: 647438AN: 1459596Hom.: 146614 Cov.: 61 AF XY: 0.446 AC XY: 323932AN XY: 726050 show subpopulations
GnomAD4 exome
AF:
AC:
647438
AN:
1459596
Hom.:
Cov.:
61
AF XY:
AC XY:
323932
AN XY:
726050
show subpopulations
African (AFR)
AF:
AC:
10967
AN:
33470
American (AMR)
AF:
AC:
15607
AN:
44412
Ashkenazi Jewish (ASJ)
AF:
AC:
11443
AN:
26112
East Asian (EAS)
AF:
AC:
28094
AN:
39662
South Asian (SAS)
AF:
AC:
46338
AN:
86198
European-Finnish (FIN)
AF:
AC:
19595
AN:
52338
Middle Eastern (MID)
AF:
AC:
2410
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
485696
AN:
1111304
Other (OTH)
AF:
AC:
27288
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
22432
44865
67297
89730
112162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
14818
29636
44454
59272
74090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.409 AC: 62160AN: 152042Hom.: 13246 Cov.: 32 AF XY: 0.408 AC XY: 30362AN XY: 74330 show subpopulations
GnomAD4 genome
AF:
AC:
62160
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
30362
AN XY:
74330
show subpopulations
African (AFR)
AF:
AC:
13659
AN:
41476
American (AMR)
AF:
AC:
5681
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1507
AN:
3468
East Asian (EAS)
AF:
AC:
3602
AN:
5152
South Asian (SAS)
AF:
AC:
2675
AN:
4826
European-Finnish (FIN)
AF:
AC:
3831
AN:
10586
Middle Eastern (MID)
AF:
AC:
123
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29701
AN:
67946
Other (OTH)
AF:
AC:
905
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1923
3846
5768
7691
9614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
602
1204
1806
2408
3010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2217
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Corneal dystrophy-perceptive deafness syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Congenital hereditary endothelial dystrophy of cornea Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.